Expectorants and Mucolytics
Expectorants and mucolytics both aim to clear mucus from the airways, but they do it in different ways. Expectorants make secretions thinner and more watery so they're easier to cough up. Mucolytics break apart the chemical structure of thick, sticky mucus to reduce its viscosity. Understanding the distinction matters because the choice of drug depends on the type of mucus problem the patient has.
Expectorants vs. Mucolytics
Expectorants promote mucus clearance by increasing the volume and hydration of respiratory secretions. With more fluid in the airways, mucus becomes less sticky and easier to move with a productive cough. The most common expectorant is guaifenesin (found in Mucinex and many OTC cough products).
Mucolytics take a different approach. Instead of adding fluid, they chemically break down the structure of mucus itself. This reduces both viscosity (thickness) and elasticity (stickiness), which improves ciliary transport and makes coughing more effective. The two key mucolytics to know are:
- Acetylcysteine (Mucomyst) — breaks disulfide bonds in mucin glycoproteins. Also used as the antidote for acetaminophen overdose, so you'll see it in other contexts too.
- Dornase alfa (Pulmozyme) — breaks down extracellular DNA in mucus. Used specifically in cystic fibrosis patients, whose mucus contains large amounts of DNA from neutrophil breakdown.
Mechanisms of Action and Side Effects
Guaifenesin (expectorant)
- Mechanism: Stimulates secretory glands in the respiratory tract to produce more fluid, watery secretions. This increases the volume of airway surface liquid and makes mucus easier to expectorate.
- Common side effects: Nausea, vomiting, diarrhea, dizziness, headache. These are generally mild and dose-related.
Acetylcysteine (mucolytic)
- Mechanism: Breaks disulfide bonds between mucin glycoproteins, which directly reduces the viscosity and elasticity of mucus. Can be given via nebulization or orally.
- Side effects: Bronchospasm (particularly concerning in asthma patients), nausea, vomiting, throat irritation, runny nose. The nebulized form has a strong sulfur smell that some patients find unpleasant and may cause nausea on its own.
Dornase alfa (mucolytic)
- Mechanism: A recombinant human DNase enzyme that cleaves extracellular DNA in pulmonary secretions, reducing mucus viscosity. Administered via nebulizer only.
- Side effects: Voice changes, pharyngitis, rash, chest pain, fever (rare).
Nursing Considerations
- Assess respiratory status (lung sounds, respiratory rate, oxygen saturation, sputum characteristics) before and after administration to evaluate drug effectiveness.
- Monitor for adverse reactions, especially bronchospasm with acetylcysteine. Have a short-acting bronchodilator available when administering nebulized mucolytics.
- Ensure adequate hydration. Fluids work alongside these medications to keep secretions thin. Dehydration will undermine the therapeutic effect, particularly with expectorants.
- Administer guaifenesin with a full glass of water to support its mechanism of action.
- Use caution with acetylcysteine in patients who have asthma or bronchial hyperreactivity, since it can trigger bronchospasm. Patients with sulfite sensitivity also need careful monitoring.
- Evaluate sputum output and quality over time. If secretions remain thick and difficult to clear, notify the healthcare provider so the treatment plan can be adjusted.
Patient Education
- Hydration is essential. Encourage patients to drink plenty of fluids throughout the day while taking these medications. This directly supports mucus thinning.
- Take guaifenesin with a full glass of water. Avoid taking it at bedtime, because increased secretions can pool in the airways during sleep and worsen coughing.
- Report adverse reactions promptly, including persistent nausea, vomiting, wheezing, or any new difficulty breathing.
- Practice effective coughing techniques: take a deep breath, hold briefly, then cough forcefully from the diaphragm rather than just the throat. Deep breathing exercises (such as incentive spirometry if ordered) help expand the lungs and mobilize secretions.
- Follow the prescribed dosage and duration. Guaifenesin is often taken as needed, but mucolytics like dornase alfa in cystic fibrosis patients are part of a daily regimen and shouldn't be skipped.
- Remind patients to inform their healthcare provider about all other medications they're taking, including OTC drugs, to avoid potential interactions. Many combination cold products already contain guaifenesin, so doubling up is a common mistake.